801-2, Jindong Mansion, No. 536 Xueshi Road, Yinzhou, Ningbo 315100, P.R.China
Home ProductsAerosol Medication

Zolmitriptan Nasal Spray Aerosol Medication Synthetic Tryptamines White Powder

Zolmitriptan Nasal Spray Aerosol Medication Synthetic Tryptamines White Powder

    • Zolmitriptan Nasal Spray Aerosol Medication Synthetic Tryptamines White Powder
  • Zolmitriptan Nasal Spray Aerosol Medication Synthetic Tryptamines White Powder

    Product Details:

    Place of Origin: China
    Brand Name: Newlystar
    Certification: GMP
    Model Number: 2.5mg, 5mg / puff, 30 puffs

    Payment & Shipping Terms:

    Minimum Order Quantity: 10, 000 bottles
    Price: Negotiation
    Packaging Details: one bottle/box
    Delivery Time: 45days
    Payment Terms: L/C, T/T
    Supply Ability: 80, 000 bottles per day
    Contact Now
    Detailed Product Description
    Product: Zolmitriptan Nasal Spray Specification: 2.5mg, 5mg / Puff, 30 Puffs
    Standard: USP Packing: One Bottle/box
    High Light:

    aerosol medicine

    ,

    aerosolized medications

    Zolmitriptan Nasal Spray Aerosol Medication Synthetic Tryptamines White Powder

     

     

    Zolmitriptan Nasal Spray 2.5mg, 5mg / puff, 30 puffs Aerosol Medication

     

    Product : Zolmitriptan Nasal Spray

    Specification : 2.5mg, 5mg / puff, 30 puffs

    Standard : USP

    Packing : one bottle/box

     

    Description :

    Zolmitriptan is a synthetic tryptamine derivative and appears as a white powder that is readily soluble in water.

     

    Indication :

    For the acute treatment of adult migraine with or without auras.

     

    Pharmacodynamics

    Zolmitriptan is a selective agonist of serotonin (5-hydroxytryptamine; 5-HT) type 1B and 1D receptors. It is structurally and pharmacologically related to other selective 5-HT1B/1D receptor agonists, and has only a weak affinity for 5-HT1A, 5-HT5A, and 5-HT7 receptors and no significant affinity or pharmacological activity at 5-HT2, 5-HT3 or 5-HT4 receptor subtypes or at alpha1-, alpha2-, or beta-adrenergic, dopamine1,; dopamine2; muscarinic, or benzodiazepine receptors. This action in humans correlates with the relief of migraine headache. In addition to causing vasoconstriction, experimental data from animal studies show that Zolmitriptan also activates 5-HT1 receptors on peripheral terminals of the trigeminal nerve innervating cranial blood vessels, which may also contribute to the antimigrainous effect of Zolmitriptan in humans.

     

    Mechanism of action

    Zolmitriptan binds with high affinity to human 5-HT1B and 5-HT1D receptors leading to cranial blood vessel constriction. Current theories proposed to explain the etiology of migraine headache suggest that symptoms are due to local cranial vasodilatation and/or to the release of sensory neuropeptides (vasoactive intestinal peptide, substance P and calcitonin gene-related peptide) through nerve endings in the trigeminal system. The therapeutic activity of zolmitriptan for the treatment of migraine headache can most likely be attributed to the agonist effects at the 5HT1B/1D receptors on intracranial blood vessels (including the arterio-venous anastomoses) and sensory nerves of the trigeminal system which result in cranial vessel constriction and inhibition of pro-inflammatory neuropeptide release.

    Contact Details
    Newlystar (Ningbo) Medtech Co.,Ltd.

    Contact Person: Luke Liu

    Send your inquiry directly to us (0 / 3000)

    Other Products